Professional Documents
Culture Documents
Mohan
Sepsis facts
severe
sepsis represent 27% of ICU admissions in UK account for 46% of all ICU bed days Mortality 30% to 50% or 500,000 deaths per year worldwide USA, the average cost per case is $22,100
Pathophysiology
Infection
Host response Neutrophil/macrophage/endothelial activation
Release of mediators
Endothelial damage
Pathophysiology CVS Generalised vasodilatation Leaky capillaries Relative hypovolemia Myocardial depression Shock Poor perfusion & organ dysfunction
Pathophysiology
RS
ARDS Abnormal renal function multi factorial Abnormal liver function Abnormal coagulation - DIC
Sepsis Definitions
General variables
T >38 or <36 HR >90 or 2SD above base lines Tachypnoea Altered mental status Significant oedema or Positive fluid balance >20 ml/kg Hyperglycaemia >7.7
Definitions
Haemodynamic variables
Definitions
Definitions
Septic shock Sepsis + hypotension (SBP <90 or MAP<60 or SBP <40 from baseline ) despite fluid resuscitation and evidence of poor perfusion
Management
Surviving sepsis guidelines 2008 Evidence-based recommendations Complete package Improve uniformity/addition of EBM Evidence of Feasibility & benefits beginning to appear
Initial Management
Optimise
Identify
Begin resuscitation immediately in patients with hypotension or elevated serum lactate 4 mmol /L; do not delay pending ICU admission (1C) Resuscitation goals (1C) CVP 812 mm Hg Mean arterial pressure 65 mm Hg Urine output 0.5 mL/kg/hr Central venous (superior vena cava) oxygen saturation 70% or mixed venous 65% Vasopresor to maintain PP If venous oxygen saturation target is not achieved (2C) Consider further fluid Transfuse packed red blood cells if required to hematocrit of 30% and/or Start dobutamine infusion, maximum 20 gkg1min1
Initial resuscitation
Fluid Therapy
No
evidence-based support for one type of fluid over another Fluid challenge based on repeated assessment
Fluid challenge
Base line HR, BP, CVP, Capillary refill 500 ml crystalloids/250 ml colloids over 30 minutes Look at the response
HR
High & Decrease transiently
CVP
Low & Increase transiently
BP
Low & Increase transiently
Action
Further fluid boluses
Observe
H/N no change
Possible overload
Management of sepsis
Vassopressor
Either norepinephrine or dopamine
is the first-choice vasopressor agent Low-dose dopamine should not be used for renal protection Vasopressin in refractory shock
Management of sepsis
Inotropic support
In patients with low cardiac output despite adequate fluid resuscitation, dobutamine may be used to increase cardiac output A strategy of increasing cardiac index to achieve an arbitrarily predefined elevated level is not recommended.
Management of sepsis
Diagnosis
Appropriate
cultures >2 blood cultures Each vascular access other appropriate fluids Diagnostic studies
Management of sepsis
Antibiotic therapy
Broad
Management of sepsis
Source control
Prompt
Further management
Steroids patients with septic shock Physiological dose(200-300mg/day) Glucose control Normalise ideally 4.4-6.1 at least <8.3 Activated protein C Adults APACHE >25
Other recommendations
Nutritional support Renal support Stress ulcer prophylaxis Maintain Hb 7-9g/dl Thromboprophylaxis Use of bicarbonate no unless PH<7.15 Consideration for Limitation of Support
Vasopressors If MAP < 65 mmHg SVO2 & Lactate Inotropes blood transfusion to target Hb 10 g/dl
R/v homodynamic parameters R/V antibiotics Glucose<8.3 mmol/l Consider steroids Consider APC Nutrition/stress ulcer prophylaxis DVT prophylaxis Ventilatory strategy Renal support Limitation of treatment
Take home
Initiate
fluid resuscitation/oxygen
Appropriate
Repeated
Brain Injury
Trauma
CVA
Hypoxic Other
brain injury
Principle of Management
Prevent 2ry Brain injury Optimize PhysiologyCPP >65,PAO2 >12,PACO2 4.5-5 Glucose, electrolytes, Temp EVACUATE Haematoma
Some Physiology
CPP=MAP-(ICP+CVP) ICP
Management
Initial Management ABCDE Hypoxia/ Hypotention kills
CT
Management
Later management 300 head up AIM MAP >90 -PaO2 >12 -PaCO2 4.5-5 -BM 4.5-8,T 32-35 Anticonvulsants Stress ulcer ,DVT prophylaxis NO evidence for Steroids, Hypotonic fluids, Glucose (unless hypoglycaemia)
Management
When
to Consider TLC